Jonathan Freve

Jonathan Freve is an experienced financial executive with a strong background in leading financial operations within the biotechnology and pharmaceutical sectors. Currently serving as Chief Financial Officer at Alentis Therapeutics, Jonathan has previously held key financial leadership roles, including Chief Financial Officer and Treasurer at Spring Bank Pharmaceuticals, Chief Financial Officer at Galecto, Inc., and Senior Director of Finance at Santaris Pharma A/S, which was acquired by F. Hoffmann-La Roche Ltd. Additionally, Jonathan contributes as a Board Member at the Liver Institute and Foundation for Education and Research.